Medical News

RSS

ECOG-ACRIN opens trial testing ivonescimab for aggressive bile duct cancer

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announced today that it will open a randomized, registration-enabling phase 2/3 clinical trial to evaluate ivonescimab combined with chemotherapy as first-line treatment for patients with advanced biliary tract cancer (BTC).

21 Oct 2026

Earned Income Tax Credit expansion negatively affected child development outcomes

As part of US welfare reforms in the 1990s to provide adequate financial support to low-income families while avoiding disincentivizing work, policymakers expanded the Earned Income Tax Credit (EITC).

21 Oct 2026

Postpartum psychosis symptoms frequently dismissed as standard baby blues

In an interview-based study in the Journal of Advanced Nursing including 15 Australian women diagnosed with postpartum psychosis over the past 10 years, women reported that they made multiple attempts to seek medical help and support, yet they encountered delayed recognition, inadequate assessment and, at times, dismissal or minimization of their concerns.

21 Oct 2026

Hurricanes pose long-term health risks for vulnerable older adults

New research in the Journal of the American Geriatrics Society indicates that older adults who rely on electricity-dependent medical devices-such as ventilators, respirators, and dialysis machines-may face substantial health risks during and after hurricanes, especially in communities experiencing severe flooding.

21 Oct 2026

Regular tea consumption linked to lower risk of vascular disease

In a Journal of Internal Medicine study, people who drank tea had a lower risk of vascular disease than non–tea drinkers.

21 Oct 2026

Supercomputer helps design more reliable AI for breast cancer diagnosis

While AI offers the ability to improve human experts' ability to diagnose and treat diseases like breast cancer, well-publicized errors across the broader AI field are cause for concern.

21 Oct 2026

A nine-year study reveals a pattern linking loneliness to heart risk

The study reveals that patterns of loneliness and social isolation significantly impact heart health, suggesting new avenues for cardiovascular risk assessment.

21 Oct 2026

Oxaloacetate supplement may help reduce chemo brain in breast cancer survivors

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a nutritional supplement containing oxaloacetate, a molecule naturally found in the body that helps cells produce energy, may help improve cognitive function and reduce the fatigue experienced by some breast cancer survivors following treatment.

21 Oct 2026

Could a hormone from our bones reveal early signs of insulin resistance?

Research reveals a link between osteocalcin and insulin resistance in obese children, suggesting early metabolic changes before glucose tolerance impairment.

21 Oct 2026

All-in-one solution for continuous microbial monitoring without production interruptions

Particle Measuring Systems (PMS), a global leader in contamination monitoring solutions, today announced the launch of the BioCapt® Single-Use STS Microbial Monitor, a sterile transfer solution that enables the introduction of viable air monitoring consumables into isolators and Restricted Access Barrier Systems (RABS) without requiring additional decontamination activities.

From Particle Measuring Systems 21 Oct 2026

Touchlight announces leadership transition, with Will Downie appointed interim CEO

Touchlight today announces that Karen Fallen is stepping down as CEO and that the Board of Directors has appointed Will Downie as Interim Chief Executive Officer.

From Touchlight 21 Oct 2026

Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Qureight, an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced it has been selected by Celea Therapeutics as the imaging CRO to support Celea’s Phase 3 SURPASS-IPF clinical trial.

From Qureight 21 Oct 2026

Why did people report feeling better during COVID-19? A French study offers clues

Assessing well-being in France (2014-2023), the study finds COVID-19 influenced scores, with health symptoms significantly affecting emotional health.

21 Oct 2026

Young adults increasingly use high-nicotine e-cigarettes, study finds

Researchers from University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science have found that high-nicotine e-cigarette use rose sharply among young adults between 2017 and 2022 and was associated with increased nicotine dependence and more persistent vaping.

21 Oct 2026

Duke initiative aims to bring dementia AI tools into clinical practice

Artificial intelligence (AI) could transform care for older adults and people living with dementia, but few tools have successfully moved from research into routine clinical practice.

21 Oct 2026

Diverse social activities may help slow age-related cognitive decline

Diverse and sustained social activities may boost cognitive performance and slow the decline in brain health associated with aging, suggest the findings of a large international study, published online in the Journal of Epidemiology & Community Health.

21 Oct 2026

Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and SPT Labtech today announced their partnership to deliver validated, automated library preparation workflows that combine Takara Bio next-generation sequencing (NGS) library preparation chemistries with SPT Labtech's firefly liquid handling platform.

From Takara Bio USA, Inc. 21 Oct 2026

Pure cranberry juice may help protect teeth from decay

Boil them, mash them, simmer them in a sauce. Whether they’re sweetening a salad, garnishing a cocktail or brightening up home décor, cranberries are an iconic ingredient in holiday festivities.

21 Oct 2026

ScionxBio announces collaboration to develop long-acting xRNA therapeutics

ScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA therapeutics, distinguished by their extended durability profile, today announced that it has entered into a worldwide strategic collaboration and licensing agreement with Sanofi to develop and commercialize extended exposure versions of certain Sanofi mRNA candidates by leveraging ScionxBio's proprietary TERA® platform.

From ScionxBio 21 Oct 2026

Combination approach slows osteosarcoma growth and prolongs survival in preclinical models

Scientists co-led by St. Jude Children's Research Hospital have identified a potential therapeutic vulnerability in some forms of osteosarcoma.

20 Oct 2026

Medical News

ECOG-ACRIN opens trial testing ivonescimab for aggressive bile duct cancer

Earned Income Tax Credit expansion negatively affected child development outcomes

Postpartum psychosis symptoms frequently dismissed as standard baby blues

Hurricanes pose long-term health risks for vulnerable older adults

Regular tea consumption linked to lower risk of vascular disease

Supercomputer helps design more reliable AI for breast cancer diagnosis

A nine-year study reveals a pattern linking loneliness to heart risk

Oxaloacetate supplement may help reduce chemo brain in breast cancer survivors

Could a hormone from our bones reveal early signs of insulin resistance?

All-in-one solution for continuous microbial monitoring without production interruptions

Touchlight announces leadership transition, with Will Downie appointed interim CEO

Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Why did people report feeling better during COVID-19? A French study offers clues

Young adults increasingly use high-nicotine e-cigarettes, study finds

Duke initiative aims to bring dementia AI tools into clinical practice

Diverse social activities may help slow age-related cognitive decline

Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies

Pure cranberry juice may help protect teeth from decay

ScionxBio announces collaboration to develop long-acting xRNA therapeutics

Combination approach slows osteosarcoma growth and prolongs survival in preclinical models

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News